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Amongst the major features of aging are chronic low grade inflammation and a decline
in immune function. The Mediterranean diet (MedDiet) is considered to be a valuable
tool to improve health status, and although beneficial effects have been reported, to
date, immunological outcomes have not been extensively studied. We aimed to test the
hypothesis that 1 year of a tailored intervention based on the MedDiet with vitamin D
(10 µg/day) would improve innate immune responses in healthy elderly subjects (65–
79 years) from the English cohort (272 subjects recruited) of the NU-AGE randomized,
controlled study (clinicaltrials.gov, NCT01754012). Of the 272 subjects forming the
United Kingdom cohort a subgroup of 122 subjects (61 in the intervention group
and 61 in the control group) was used to evaluate ex vivo innate immune response,
phenotype of circulating immune cells, and levels of pro- and anti-inflammatory markers.
Odds Ratio (OR) was calculated for all the parameters analyzed. After adjustment by
gender, MedDiet-females with a BMI < 31 kg/m2 had a significant upregulation of
circulating CD40+CD86+ cells (OR 3.44, 95% CI 1.01–11.75, P = 0.0437). Furthermore,
in all MedDiet subjects, regardless of gender, we observed a MedDiet-dependent
changes, although not statistically significant of immune-critical parameters including
T cell degranulation, cytokine production and co-receptor expression. Overall, our study
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showed that adherence to an individually tailored Mediterranean-like dietary pattern
with a daily low dose of vitamin D3 supplements for 1 year modified a large variety of
parameters of immune function in healthy, elderly subjects. We interpreted these data
as showing that the MedDiet in later life could improve aspects of innate immunity and
thus it could aid the design of strategies to counteract age-associated disturbances.
Clinical Trial Registration: clinicaltrials.gov, NCT01754012.
Keywords: aging, dietary intervention, nutrition, inflammation, elderly, NU-AGE
INTRODUCTION
Aging is an irreversible process that is associated with a
significant decline of the immune system that leads to increased
susceptibility to infection, reduced efficiency of vaccination
protocols and significantly higher incidence of autoimmune
disorders and cancer (Castle, 2000; Dewan et al., 2012).
Chronological age may also result in vascular aging with
deterioration in arterial function (Jani and Rajkumar, 2006)
associated with cardiovascular diseases (CVD) that are the most
common world-wide cause of morbidity and mortality in persons
aged over 65 years, particularly those with diabetes mellitus.
The negative impact on vascular function compromises the
ability to resist oxidative stress and inflammation. Aging is
characterized by a chronic, low grade inflammatory status termed
“inflammaging” (Franceschi et al., 2000, 2007; Monti et al., 2017),
which plays a critical role in the pathogenesis of major age-
related chronic diseases and in important geriatric conditions
(De Martinis et al., 2006; Pedersen, 2009; Lencel and Magne,
2011; Franceschi and Campisi, 2014) and in so doing contributes
to both a poor quality of life and elderly mortality (Cevenini
et al., 2013; Varadhan et al., 2014). Increased production of
inflammatory mediators and the simultaneous down-regulation
of anti-inflammatory ones takes place in a variety of tissues,
organs and systems including adipose tissue, muscles, brain,
and contribute to the onset and progression of such a systemic
inflammatory state (Cevenini et al., 2010, 2013).
Immunosenescence is a hallmark of the aging organism and
both the innate and adaptive arms of the mucosal and systemic
immune systems are affected (Maijó et al., 2014; Man et al., 2015),
with alterations in constituent cells linked to the onset of chronic
diseases and it is generally accepted that immunosenescence is
accelerated in those subjects who present inflammaging. The
design of interventional strategies to delay, halt or even possibly
reverse immunosenescence requires a detailed understanding of
the aging process at cellular level.
Although the individual genetic make-up that dictates
immune responses cannot be modified, other factors contributing
to aging such as lifestyle and diet (Pae et al., 2012) could be
changed in the attempt to halt/reverse the progression of the
detrimental effects of aging on immune effectiveness (Franceschi
et al., 2017). To this end, the adoption of nutritional regimen
to improve immune function in the elderly is a potentially
important approach. Indeed, a diet rich in fruit, vegetables,
legumes, unrefined cereals and olive oil and accompanied by low
intake of meat, dairy products and alcohol consumption typical
of the Mediterranean is effective in decreasing the incidence
of cardiovascular and other chronic diseases and increased
longevity (Mena et al., 2009; Vasto et al., 2012; Casas et al., 2014,
2018; Martinez-Gonzalez et al., 2015; Santangelo et al., 2018).
The recognition of nutrition as a possible determinant of
successful aging was acknowledged by the European Union by
funding a dietary intervention study, the NU-AGE project1.
A multidisciplinary European consortium developed a tailored
dietary strategy to address the needs of the elderly (65–79 years)
for promoting healthy aging in Europe. The dietary strategy
included the daily supplementation of a low dose of vitamin D
(10 µg or 400 IU/day) to minimize differences between study
sites part of the whole NuAge project across different areas of
Europe that differed in the diet and exposure to sunlight, two
very critical factors for determining the vitamin D status. The
aim of the study was to examine the effect of consuming a
Mediterranean-like dietary pattern (NU-AGE diet) with vitamin
D3 for 1 year on a large variety of parameters of immunity that




This study was a part of the larger multi-national NU-AGE
study, a parallel-group, multi-centric, randomized, controlled
clinical trial of 1-year duration (clinicaltrials.gov, NCT01754012)
aimed at assessing the effects of the MedDiet in healthy aging
[European seven framework project (FP7); Grant Agreement
no. 2664862]. Full details of the study protocol have been
described elsewhere (Santoro et al., 2014). It was not possible to
blind the study to the participants or scientists responsible for
managing the dietary intervention, but all the sample analysis was
blinded. All subjects provided written informed consent prior to
their inclusion in the study. This study reports data from 272
subjects recruited at baseline in the NU-AGE English cohort (134
control, 138 MedDiet). One arm of the study aimed to study
the effects of dietary intervention on a variety of parameters
of the innate immune system. To this end, 122/272 subjects
of the United Kingdom cohort were utilized to study immune
responses, (61 control, 61 MedDiet). After 1 year, 115/122
subjects, among those studied for immune responses, completed
1www.nu-age.eu
2http://www.nu-age.eu/
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TABLE 1 | Quantitative dietary guidelines given to study participants.
Food group Quantity required in dietary intervention
Whole grains 6 servings per day; 1 serving = 25 g bread, 50 g breakfast cereal
Fruits 2 servings per day; 1 serving = 1 apple, 1 banana, 8 small plums
Vegetables and legumes 330 g per day, once per week 200 g legumes
Dairy and cheese 500 ml dairy per day (of which 30 g cheese)
Fish and other seafood 2 times per week; 1 portion = 125 g
Meat and poultry 4 times per week; 1 portion = 125 g
Nuts 2 times per week; 20 g portion
Potatoes, pasta and rice 150 g per day; 80 g (raw weight) whole grain rice or pasta at least twice a week
Eggs 2–4 times per week
Oil or fat 20 g oil per day, 30 g margarine per day; maximum of 50 g fat per day. Should be olive oil and low fat margarine rich in MUFA and PUFA
Alcohol Maximum of 1–2 glasses per day for men, and 1 glass per day for women. Preferably red wine, if not abstain
Fluid 1.5 liter per day, including milk
Salt Reduce added salt, and intake of ready meals (soups, gravy, and sauce)
Sugar Limit consumption of sugar and sweetened drinks (replace with fruit or yogurt, no/reduce sugar in tea or coffee).
the intervention. Participants were independently living in their
own home. Specific inclusion criteria were as follows: men
or women aged 65–79 years; with no chronic disease, such
as cancer, organ failures for the last 2 years; responsible for
own meal choices and preparation; willing to make changes to
their habitual diet for 1 year. Exclusion criteria were: current
disease (e.g., cancer or dementia); organ failure or organ
failure requiring a special diet; the following chronic diseases:
severe heart disease, kidney disease, respiratory insufficiency,
liver cirrhosis; diabetes Mellitus type 1. Also, exclusion criteria
included long-term use of corticosteroids, use of non-steroidal
anti-inflammatory drugs, use of antibiotics within the previous
2 months, change in habitual medication use (e.g., statins,
thyroxin) within 3 months prior the beginning of the study,
participation in another current study involving either dietary
interventions or sampling/donation of blood, malnutrition (BMI
lower than 18.5 kg/m2); body weight loss of more than 10%
within 6 months. Participants were assigned randomly (1:1) to the
control or intervention groups, after stratification by sex, age (65–
72 or >72–79 years), frailty status (pre-frail or non-frail), and
body mass index (<25 or ≥25 kg/m2). Randomization was done
by computer-generated allocation and ran on Python interpreter
(version 2.6 or 2.7). The majority of the subjects (81%) were
non-frail; the remainder were pre-frail (19%).
Dietary Intervention
The NU-AGE dietary intervention has been previously described
(Berendsen et al., 2014). In brief, all participants (control and
intervention groups) completed a 7-day food record diary within
2 weeks after the baseline assessment. This was followed by
an interview with a specialized team member to review the
records. The consumed food recorded in the food diary was
coded according to standardized coding procedures (Berendsen
et al., 2014). The control group, following a habitual diet, received
only a leaflet with national dietary guidelines. The intervention
group was given individually tailored Mediterranean diet advice
plus a daily vitamin D3 supplement of 10 µg. The combination of
the Mediterranean dietary pattern and vitamin D is henceforth
referred to solely as MedDiet. The nutritional intervention
was from the Food Based Dietary Guidelines for older adults
(Berendsen et al., 2014) conducted by a dietician/nutritionist
using individual education using a Motivational Intervention
technique. Participants were advised to consume on average
15–20% of their daily energy from protein, 50–60% from
carbohydrate, 25–30% from fat (<10% from saturated fat, <1%
from trans fatty acids, <12% from polyunsaturated fatty acids,
and 8–28% from monounsaturated fatty acids). In addition,
subjects were recommended to consume 30–40 g/day of fiber,
<10–20 g/day of preferably red wine (1 serving/day for women
and 2 for men), 2 g/day sodium, 1.3 g/day potassium, 10 mg/day
iron, 15 µg/day of vitamin D3, 400 µg/day of folate, and 5 µg/day
of vitamin B12. The MedDiet cohort (n = 61) received individual,
tailored dietary advice (summary in Table 1) based on dietary
reference values in the United Kingdom3 and recommendations
from bodies including the modified My Pyramid for Older Adults
(Peregrin, 2008; Shelnutt et al., 2009), European Commission
(Commission of the European Communities and Nutrient and
Energy Intakes for European Community, 1993), and Institute
of Medicine (Institute of Medicine of the National Academies
and Dietary Reference Intakes, 2006). Subjects in the control
group (n = 61) were given a standard healthy-living advice leaflet
from the British Dietetic Association and asked to maintain their
normal dietary habits over the course of the year.
Isolation of Mononuclear Cells
Blood collected in vacutainers (Becton Dickinson, Oxford,
United Kingdom) containing ethylenediaminetetraacetic acid
(EDTA) was centrifuged at 2200 rpm to separate plasma
from the pelleted cells. Plasma was collected and stored at
−80◦C for future analyses. Cell pellets were diluted 1:3 with
Hank’s Balanced Salt Solution (HBSS; Sigma-Aldrich, Dorset,
United Kingdom) and peripheral blood mononuclear cell
(PBMCs) were separated using Leucosep tubes according to
3https://www.gov.uk/government/publications/sacn-dietary-reference-values
-for-energy
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the manufacturer instructions (Greiner Bio-one). PBMCs were
collected from the interface, washed and cell counts were adjusted
to 4 × 106 viable cells/mL with ‘complete’ DMEM/F12 (Life
Technologies Ltd., Paisley, United Kingdom) supplemented with
100 U/mL penicillin, 100 µg/mL streptomycin, and 50 mL of FBS
(Sigma, United Kingdom).
Co-receptor Expression Induced by
Toll-Like Receptor (TLR) Agonists
Peripheral blood mononuclear cells at 1 × 106 viable cells/mL
(final concentration) in complete DMEM/F12 were cultured with
50 µg/mL Poly A:U, 2.5 µg/mL Imiquimod-R837, 25 µg/mL
ODN-M362, 5 µg/mL LPS-ED and 50 ng/mL Pam2CSK4
(Invivogen, San Diego, CA, United States) or without for 22 h in
24-well flat-bottom plates at 37◦C in an atmosphere of 5% CO2
in air. Cell-free supernatants were collected and stored at −80◦C
until analysis. Freshly collected cells were washed and stained for
expression of costimulatory molecules by incubation for 20 min
at 20◦C with fluorochrome-labeled monoclonal antibodies
(mAbs): anti-CD154 Brilliant Violet (BV) 421 (Biolegend, San
Diego, CA, United States), anti-CD80 Alexa Fluor (AF488)
(Biolegend), anti-CD86 Allophycocyanin (APC) (Biolegend),
anti-HLA-Dr AF700 (Biolegend), anti-CD152 Phycoerythrin
(PE) (Biolegend), anti-CD40 Phycoerythrin-Cyanine 7 (PE/Cy7)
(Biolegend), and anti-CD1d APC (Biolegend). Negative control
cells were incubated with the corresponding isotype-matched
negative control mAbs conjugated with BV421, AF488, APC,
AF700, PE/Cy7, and PE (Biolegend). Cells were washed, then
fixed with Formalin 1X, before analysis by flow cytometry
(EC800 Sony Biotechnology Inc., Surrey, United Kingdom).
Analysis was performed using FlowJo software (FlowJo, Oregon,
United States).
In Vitro Responses to TLR Agonists
Culture supernatants were collected following culture with TLR
agonists as described above. Quantitative determination of IFN-
α, IFN-β, IFN-γ, IL-12p40, IL-12p70 present in the culture
supernatants was performed by ProcartaPlexTM Immunoassay
(eBioscience, United Kingdom) according to the manufacturer’s
instructions and analysis using Luminex 200 instrumentation
(Luminex Corporation, Netherlands). The immunoassay kits
were specific for human cytokines. Assay sensitivities were
0.6 pg/mL for IFN-α, 8.54 pg/mL for IFN-β, 8.89 pg/mL
for IFN-γ, 1.81 pg/mL for IL-12p40, and 6.30 pg/mL IL-
12p70. The soluble expression of SOCS3, IL-12Rβ1, and IL-
12Rβ2 in the supernatants was performed using enzyme-linked
immunosorbent assay (ELISA) kits (Antibodies-online, Atlanta,
GA, United States) according to the manufacturer’s instructions.
The assay sensitivities were 15.6 pg/mL for SOCS3, 0.156 ng/mL
for IL-12Rβ1, and 0.156 ng/mL IL-12Rβ2 and ELISA plates were
read in a microplate reader at 450 nm (Benchmark Plus Bio-Rad,
Hercules, CA, United States).
T Cell Proliferation
Peripheral blood mononuclear cells at 2 × 106 viable cells/mL
(final concentration) in complete DMEM/F12 were cultured
with 5 µg/mL of Staphylococcal enterotoxin B (SEB; Sigma-
Aldrich, United Kingdom) for 6 days in 24-well flat-bottom
plates at 37◦C and 5% CO2. Cells were stained with anti-CD3
BV421 (Biolegend), and anti-CD8 AF488 (Biolegend) for 20 min
at 20◦C. T cell proliferation was measured using the Coulter
DNA Prep Reagent Kit (Beckman Coulter Ltd., High Wycombe,
United Kingdom) according to the manufacturer’s instructions.
Data were acquired by Flow cytometry (EC800 Sony). Analysis
was performed using FlowJo software (FlowJo, United States).
Dendritic Cell Subtypes
Enumeration/Ratio
DCs were enumerated in heparinized blood using a Blood
Dendritic Cell Enumeration Kit (Miltenyi Biotec Ltd., Surrey,
United Kingdom) according to the manufacturer’s instructions.
The anti-BDCA cocktail contains: anti CD303 (BDCA-2)
Fluorescein (FITC), anti-CD1c (BDCA-1) PE, anti-CD14
Phycoerythrin-Cyanine 5 (PE-Cy5), and anti-CD19 PE-Cy5 for
the determination of plasmacytoid (pDC) and myeloid (mDC)
DC. Antibodies to CD14 and CD19 antigens were used for
exclusion of monocytes and B cells, respectively. To enable
quantification in terms of absolute counts/µL blood, Flow
count fluorospheres (Beckman Coulter) were added to each
sample prior to flow cytometric (EC800 Sony) data acquisition.
Analysis was performed using FlowJo software (FlowJo,
United States). The ratio of mDC to pDC were calculated by
applying the following formula DC = number of DC/number
count beads× concentration).
CD8 T Cell Degranulation
Peripheral blood mononuclear cells at 1 × 106 viable cells/ml
(final concentration) in complete DMEM/F12 were placed into
each of two sterile tubes labeled ‘test’ or ‘control.’ Cells in the
‘test’ tube were incubated with anti-CD107a AF647 (Biolegend)
for 15 min, before addition of 1.1 µg/mL SEB (Sigma-Aldrich,
United Kingdom) as stimulant and 5 µL ethanol. The ‘control’
sample was not stimulated but had 5 µL (1 µM) colchicine
(Sigma, Missouri, United States) in ethanol added to minimize
spontaneous degranulation. In both tubes the final volume was
adjusted 1 mL with tissue media culture. Tubes were incubated
for 5 h at 37◦C and 5% CO2, then washed and stained with
anti-CD3 AF488 (Biolegend) and anti-CD8 PE (Biolegend).
After further washing and fixation with 1% formalin, data were
acquired by flow cytometry (EC800 Sony) and analyzed using
FlowJo software.
Granulocyte Oxidative Burst Activity
The quantitative determination of leukocytes oxidative burst
was performed in whole blood using the PhagoburstTM kit
(Glycotope Biotechnology, Heidelberg, Germany) according to
the manufacturer’s instructions. Burst activity in leukocytes was
evaluated after stimulation with N-formyl-methionineleucine-
phenylalanine (fMLP), a moderate stimulus. The generation of
ROS was measured by assessing the oxidative conversion of the
fluorogenic substrate dihydorohomdamine-123 into rhodamine.
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FIGURE 1 | Flow chart summarizing recruitment and retention of study participants. 272 volunteers were recruited at baseline in the NU-AGE English (Norwich)
cohort (134 control, 138 MedDiet) for the dietary intervention. This study (blue boxes) focuses on the effects of dietary intervention on a variety of parameters of the
immune responses.
Data were acquired by flow cytometry (EC800 Sony) and
analyzed using FlowJo software.
Plasma Cytokines
Plasma samples stored at−80◦C were thawed for the quantitative
determination of IL-2, IL-9, IL-22, IL-23 by ProcartaPlexTM
Immunoassay (eBioscience, Hatfield, United Kingdom)
according to the manufacturer’s instructions. Analysis was
performed using Luminex 200 instrumentation (Luminex
Corporation, Netherlands). Assay sensitivities were 4.44 pg/ml
for IL-2, 11 pg/ml for IL-9, 33 pg/ml for IL-22, 19 pg/ml for
IL-23.
T Cell Phenotyping
Peripheral blood mononuclear cells at 1 × 106 viable cells/mL
(final concentration) in complete DMEM/F12 were incubated
with anti-CD3 AF700 (Biolegend), anti-CD28 Pacific blue (PB)
(Biolegend), anti-CD161 PE-Cy7 (Biolegend), anti-CD158d PE
(Biolegend), and anti-TCR Vα24-Jα18 FITC (Biolegend) or the
corresponding isotype controls. All antibodies were purchased
from Biolegend (United Kingdom). After 20 min at 20◦C cells
were washed, and fixed with 1% formalin. Data were acquired
by flow cytometry (EC800 Sony) and analyzed using FlowJo
software.
Statistical Analysis
Primary endpoints of the NU-AGE study were changes in
immune responses; and a variety of secondary endpoints
TABLE 2 | Physical features of the study participants.
Characteristics Control n = 61 MedDiet n = 61 All subjects
n = 122
Age (years) 70.63 ± 3.77 69.97 ± 4.20 70.27 ± 4.02
Body mass index
(kg/m2) baseline
26.9 ± 3.3 26.4 ± 4.5 26.7 ± 4.0
Body mass index
(kg/m2) final
26.7 ± 3.5 26.2 ± 4.4 26.4 ± 4.1
Women % 63.0 58.2 60.4
Pre-frail % 18.5 19.5 19
Physical features of the participants were recorded at baseline and at the end of
the 1-year dietary intervention period.
(ClinicalTrials.gov, NCT01754012). This work focuses on the
effects of MedDiet on parameters of immune function. Samples
from all volunteers were run in triplicate for each assay.
Associations were investigated based on an adjusted Mantel–
Haenszel odds ratio (OR), for a post-study change in the
intervention group compared to the controls, some analysis
were stratified by gender. Associations were evaluated using
a Mantel–Haenszel chi-squared test. Confidence intervals were
calculated using the method of Robins–Breslow–Greenland. Sex
interactions were evaluated using Tarone’s test of homogeneity.
Odds ratios were calculated such that a value less than 1
corresponds to a reduction in the intervention arm compared to
the control arm. P-values were considered significant at less than
0.05.
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FIGURE 2 | Effects of MedDiet on CD40+CD86+ expression following in vitro challenge with TLR agonists. PBMC were cultured with a cocktail of TLRs agonists
(PolyA:U, Imiquimod, ODN-M362, LPS, Pam2CSK4) for 22 h. Forest plot of the study of the CD40+CD86+ lymphocytes comparing the association between
Mediterranean diet and normal diet after 1 year of intervention with the random effect model. Associations were investigated based on an adjusted Mantel–Haenszel
odds ratio (OR), stratified by gender (A) or BMI > 31 kg/m2 (B). OR and 95%Cl were calculated. Cl, confidence interval.
RESULTS
Participants
Figure 1 shows the recruitment and retention of the volunteers.
Quantitative dietary guidelines given to study participants and
physical features of the cohort, such as age, body mass index
(BMI) at baseline and at the end of the study, gender and
percentage of pre-frail individuals of the cohort studied are
detailed in Tables 1, 2, respectively.
TLR Agonist Induced Co-receptor
Expression and Cytokine Secretion
The expression of a large panel of costimulatory molecules
comprising CD154, CD80, CD86, HLA-Dr, CD40, CD152,
and CD1d after in vitro challenge with TLR agonists was
studied in lymphocyte and monocyte/DC populations.
Expression of selected co-receptors monitored after stimulation
is expressed as percentage (%) upregulation compared
to expression on unstimulated resting cells. A gender-
specific effect of the MedDiet was observed within the
lymphocyte population with a significant upregulation
of CD40+CD86+ cells (OR 3.44, 95% CI 1.01–11.75,
P = 0.0437) observed in female study participants. Interestingly,
this was restricted to individuals with BMI < 31 kg/m2
(Figure 2).
From all the other markers studied (CD154, CD80, CD86,
HLA-Dr, CD40, CD152, and CD1d) no significant changes were
found in the monocyte/DC populations (Table 3).
Following in vitro TLR stimulation, levels of selected cytokines
were assessed in the culture supernatants. Overall, the MedDiet
intervention did not significantly affected TLR-induced cytokine
production (Table 4). On the other hand there were trends
toward increased production of IFN-β (OR 1.98, 95%CI 0.86–
4.53, P = 0.1056), and decreased production of IL-12Rβ1 (OR
0.50, 95%CI 0.22–1.13, P = 0.0929), SOCS3 (OR 0.50, 95%CI
0.21–1.18, P = 0.1108) and the ratio between IL-12p40/IL-
12p70 (OR 0.54, 95%CI 0.26–1.16, P = 0.1122) (Figures 3, 4).
Gender stratification did not reveal any differences in cytokine
production. Taken together these data suggested that a prolonged
period of exposure to the MedDiet might result in more profound
changes in the immunological parameters evaluated.
T Cell Proliferation, CD8 T Cell
Degranulation and Granulocyte Oxidative
Burst Activity
First, the T cell proliferation response to 6-day SEB stimulation
was compared to cells cultured in the absence of any stimulation.
There were no significant differences between the control and
TABLE 3 | Effects of MedDiet on the expression of co-stimulatory molecules.
Phenotype OR (95%Cl) P-value
CD154 0.84 (0.36–1.99) 0.6953
CD80 1.10 (0.50–2.41) 0.8053
CD86 1.07 (0.36–3.16) 0.9005
HLA-Dr 0.43 (0.18–1.06) 0.0655
CD40 0.92 (0.41–2.06) 0.8404
CD152 1.04 (0.45–2.37) 0.9313
CD1d 1.18 (0.52–2.69) 0.6859
Peripheral blood mononuclear cell were cultured with a cocktail of TLRs agonists
(PolyA:U, Imiquimod, ODN-M362, LPS, Pam2CSK4) for 22 h. Expression of the co-
stimulatory molecules was monitored by flow cytometry Odd ratio (OR) and 95%Cl
and p-values are shown.
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MedDiet intervention groups, when comparing the change of T
cell proliferation after 1 year of intervention (Table 5). Also, CD8
T cell degranulation was measured as % of CD107a expression on
CD3+CD8+ cells induced by SEB stimulation, and the oxidative
burst activity of granulocytes measured as % oxidizing cells
within the granulocyte population; the MedDiet had no effect in
TABLE 4 | Effects of MedDiet on in vitro production of cytokines.
Cytokine OR (95%Cl) P-value
IFNα 1.49 (0.54–4.11) 0.4415
IFNβ 1.98 (0.86–4.53) 0.1056
IFNγ 1.19 (0.51–2.75) 0.6854
IL-12p40 0.84 (0.38–1.83) 0.6582
IL-12p70 1.62 (0.74–3.52) 0.2228
IL-12p40/IL-12p70 0.54 (0.26–1.16) 0.1122
IL-12Rβ1 0.50 (0.22–1.13) 0.0929
IL-12Rβ2 1.04 (0.40–2.66) 0.9396
SOCS3 0.50 (0.21–1.18) 0.1108
Peripheral blood mononuclear cell were cultured with a cocktail of TLRs agonists
(PolyA:U, Imiquimod, ODN-M362, LPS, Pam2CSK4) for 22 h and levels of
cytokines determined in culture supernatants by ELISA assay. Odd ratio (OR) and
95%Cl and p-values are shown.
altering both parameters after 1 year of intervention (Table 5),
although a trend toward increased degranulation in the MedDiet
intervention group was observed. No gender-specific differences
were noted.
Dendritic Cell Subtypes
It has been shown that DC populations are affected by the aging
process, and we have previously shown that the MedDiet had
no effect on the numbers of mDCs or pDCs (Jing et al., 2009;
Clements et al., 2017). Here we determined whether the MedDiet
intervention had an impact on the ratio between mDCs and
pDCs. DC subpopulations were identified and enumerated by
using four-color flow cytometry in whole blood. Figure 5 shows a
trend toward decrease, but not statistically significant, in the ratio
of mDC/pDC (P = 0.0536).
Expression of Co-stimulatory Molecules
on Freshly Isolated PBMC
We then sought to investigate the effects of the MedDiet on
the expression of the co-stimulatory molecules CD28, KIRDL4
(CD158d), CD161 and TCR Vα24-Jα18 (NKT) on freshly isolated
PBMCs. We observed that 1-year intervention had no effect on
the expression of these immunoregulatory molecules between the
different study groups (Table 6). However, a trend toward higher
FIGURE 3 | Effects of the MedDiet on cytokine expression following in vitro challenge with TLR agonists-all individual values. PBMC were cultured with a cocktail of
TLRs agonists (PolyA:U, Imiquimod, ODN-M362, LPS, Pam2CSK4) for 22 h. Levels of cytokines were determined in culture supernatants. Representation of the
individual values for IFN-β (A), IL-12p40/70 ratio (B), SOCS3 (C) and IL-12Rβ1 (D) concentration in all the volunteers at baseline and after 1 year of intervention.
Results showed a tendency toward increased production of IFN-β (OR 1.98, 95%CI 0.86–4.53, P = 0.1056), and decreased production of IL-12Rβ1 (OR 0.50,
95%CI 0.22–1.13, P = 0.0929), SOCS3 (OR 0.50, 95%CI 0.21–1.18, P = 0.1108) and the ratio between IL-12p40/IL-12p70 (OR 0.54, 95%CI 0.26–1.16,
P = 0.1122. OR = odds ratio), CI, confidence intervals.
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FIGURE 4 | Cytokine expression following in vitro challenge with TLR agonists- Changes (1) of the parameter values in MedDiet and control diet at baseline and after
1-year of intervention. 1 of the parameters at baseline (T0) and after 1-year (T1) for IFN-β (A), IL-12p40/70 ratio (B), SOCS3 (C), and IL-12Rβ1 (D) concentration
were calculated and compared. For each parameter, the mean ± SD of the 1 at T0 and T1 for the control group and MedDiet group is shown in the relevant inset.
frequency of CD3+CD28+ cells in the MedDiet intervention
group was seen in both genders (OR 2.19, 95%CI 0.92–5.21,
P = 0.1174) (Figure 6).
TABLE 5 | Effects of MedDiet on T cell proliferation, CD8 T cell degranulation and
granulocyte oxidative burst activity.
Phenotype OR (95%Cl) P-value
T Cell proliferation (G2 + M Phase) 0.67 (0.27–1.65) 0.3817
% CD8 T cell degranulation 2.13 (0.77–5.91) 0.1396
Oxidative burst test (GeoMean) 2.03 (0.53–7.70) 0.2922
Peripheral blood mononuclear cell were treated in vitro as described in Section
“Materials and Methods” using PBMC for T cell proliferation and CD8 degranulation
or whole blood for granulocyte burst activity. Odd ratio (OR) and 95% confidence
intervals (Cl) for % CD8 T cell degranulation, and percentage (%) of T cell
proliferation (G2 + M phase) and Geomean of oxidative burst test. P-values are
shown.
Plasma Biomarkers
Plasma was used to monitor the levels of the regulatory cytokines
IL-9, IL-23, IL-2, IL-22 prior and after the 1-year dietary
intervention. The cytokines IL-9 and IL-23 in plasma were above
the lower limit of detection in only 4 of the 115 volunteers
analyzed. IL-2 was present in more than 90% and IL-22 in
more than 60% of the plasma samples analyzed. The statistical
analysis of IL-2 and IL-22 did not show any significant MedDiet-
associated change (Table 7).
DISCUSSION
The MedDiet has been shown to down-regulate cellular and
soluble inflammatory biomarkers related to the atherogenic
process in subjects at high risk of CVD (Mena et al., 2009;
Casas et al., 2014) and metabolic syndrome (Esposito et al.,
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FIGURE 5 | Effects of MedDiet on dendritic cell (DC) subpopulations. Whole blood was used at baseline and at the end of the 1-year dietary intervention to determine
myeloid (m)DC and plasmacytoid (p)DC ratio. Representation of the gating strategy for the DCs enumeration is shown in (A–C). (D) Boxplot showing the difference in
the control and diet groups for mDC/pDC ratio right panel. A decrease, but not statistically significant of the ratio of mDC/pDC (P = 0.0536) was observed.
2004; Fragopoulou et al., 2010). However, the immunological
outcomes have not been extensively studied. It is important to
highlight that the MedDiet was supplemented with Vitamin D3
(10 µg/day, 400 IU). The reason for giving a low dose vitamin D
supplement was to minimize differences between study sites part
of the whole NuAge project, which covered North, South, East
and West Europe in which habitual diet and sunlight exposure
affect vitamin D status. This combined intervention design does
not allow defining the relative influence of the MedDiet and/or
TABLE 6 | Effects of MedDiet on co-stimulatory Molecules.
Phenotype OR (95%Cl) P-value
CD28 1.03 (0.47–2.26) 0.9387
KIR2DL4 (CD158) 1.14 (0.53–2.45) 0.7443
CD161 1.09 (0.26–4.59) 0.9116
TCRVα24-Jα18 (NKT) 0.91 (0.38–2.17) 0.8352
Freshly collected PBMCs were stained for expression of costimulatory molecules
by incubation with fluorochrome-labeled monoclonal antibodies. Odd ratio (OR)
and 95% Cl and p-values are shown.
vitamin D on innate immune parameters. However, it has to be
stressed that previous study showed that higher daily dose of
vitamin D supplementation appeared to be effective on innate
immunity and T cell reactivity (Prietl et al., 2013; Bashir et al.,
2016). In our volunteers, adherence to a MedDiet diet for 1 year
led to significant increase in the expression of CD40+CD86+
lymphocytes in women with a BMI < 31. The initiation of an
adaptive immune response, requires multiple signals, including
the expression of costimulatory molecules. CD40 is expressed
in B cells and APCs and contribute to activate T cells through
the CD40 ligand, in the absence of CD40 many cellular and
immune functions are defective (Quezada et al., 2004). CD86 is
also necessary for T cell activation and survival, is the ligand for
CD28 and CTLA-4 and works in tandem with CD80. As these
costimulatory molecules are important in immune activation,
an association with gender may be related to the fact that
women exhibit stronger cellular- and humoral-mediated immune
responses compared to men, with a higher risk of autoimmune
disease.
Within the MedDiet group we observed that the ratio
of IL-12p40/IL-12p70 tended to decline. IL-12 up-regulates
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FIGURE 6 | Expression of co-stimulatory molecules on freshly isolated PBMC. PBMCs were stained with CD3 and CD28 antibodies. All individual values for both the
MedDiet and control group at T0 and T1 are shown (A). A trend toward higher frequency of CD3+CD28+ cells in the MedDiet intervention group was seen in both
genders (OR 2.19, 95%CI 0.92–5.21, P = 0.1174). Also, changes (1) of parameter values in MedDiet and control diet at baseline and after 1-year of intervention
were determined (mean ± SD in inset) and compared (B).
the expression of its own receptor, and elderly individuals
have increased production of IL-12. The biological activity of
the IL-12 is driven by the heterodimeric molecule IL-12p70,
while IL-12p40 may antagonize IL-12. Indeed, total IL-12, IL-
12p40, and the ratio IL-12p40/IL-12p70 increase significantly
in aging (Rea et al., 2000). So, a decrease of the ratio IL-
12p40/IL-12p70 may improve IL-12 functionality in elderly
people. If this was the case, it is plausible that increased
functionality of IL-12 might contribute to inflammageing.
Also, a trend of decreased secretion of IL-12Rβ1 in the
intervention group was observed. IL-12Rβ1 is a type 1
transmembrane receptor physically associated with the p40-
domain common to both IL-12/IL23 and promotes their
respective signaling pathways (Robinson, 2015). Regarding the
trend in higher IFN-β but lower SOCS3 production in the
MedDiet intervention group, IL-12 and IFN- β both signal
through STAT4 phosphorylation, and a defective type I IFN
response is described in T cells from elderly people (Li
et al., 2015). Higher production of type I IFN may improve
the immune response of elderly people against infection.
Upregulation of TGF-β would therefore result in suppression of
pro-inflammatory IL-12 and, also SOCS3 that down-regulates
the STAT4-mediated IL-12 signaling by binding to the STAT4
docking site in IL-12Rβ2 (Yamamoto et al., 2003). SOCS3
proteins are constitutively expressed in naïve T helper cells and
tends to decrease after cell stimulation. In aging, expression of
SOCS3 is higher than in young people and does not decrease
after stimulation (Tortorella et al., 2006). Our results showing a
trend toward lower expression of SOCS3 after TLR stimulation
would suggest the potential of MedDiet to exert beneficial
effects.
DCs in human peripheral blood are divided in two
subsets. Myeloid (m)DC are characterized by the production
of high levels of IL-12 when stimulated with tumor necrosis
factor-α or CD40 ligand and trigger a Th1-polarized immune
response. Plasmacytoid (p)DCs drive an IL-4-independent Th2
polarization of naive T cells and secrete high levels of type I
IFN, and IL-12 in response to certain bacteria (Stout-Delgado
et al., 2008). In the elderly people, a decrease in pDCs but
not mDCs (Shodell and Siegal, 2002; Pérez-Cabezas et al.,
2007; Jing et al., 2009) was reported although others have
reported conflicting results (Della Bella et al., 2007). However,
it appeared that in frail individuals both populations are
affected (Jing et al., 2009; Clements et al., 2017). Our data
did not show any significant change in the mDCs and pDC
populations in the control group compared to the intervention
group, but it would appear that the mDC/pDC ratio tend
to decrease. This finding suggests a TH2 predisposition of
immune responses in the MedDiet group related to a polarized
mDC:pDC balance toward pDCs, but a prolonged intervention
study would be needed to confirm and possibly extend this
observation.
The number, phenotype, and functions of NK cells are affected
by the aging process in humans (Gayoso et al., 2011) and NKT
cell numbers are increased (Peralbo et al., 2007). T cells from
aging individuals showed increased expression of KIR whose
expression is mostly found on senescent memory T cells that
TABLE 7 | Effects of MedDiet on plasma levels of regulatory cytokines.
Cytokine OR (95%CI) P-value
IL-2 0.87 (0.40–1.86) 0.7133
IL-9 – –
IL-22 0.66 (0.28–1.55) 0.3427
IL-23 – –
Baseline and post-dietary intervention plasma levels of cytokines were determined
using Luminex instrumentation. Odd ratio (OR) and 95% Cl and p-values are shown.
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have lost CD28 expression (Li et al., 2008). Cells that produce
IL-17 express CD161, and in the elderly, there is a decrease in
expression of CD161+CD4 T cells (Lee et al., 2011). Our study
shows no change in the expression of these markers following
MedDiet intervention.
The majority of studies on aging to date have involved at-risk
populations such as, for example individuals with pre-existing
hypertension or metabolic syndrome. Instead our study focused
on healthy elderly that did not have any signs of chronic disease
or significantly impaired immune function; it is likely that this
approach might have made more difficult to observe striking
beneficial effects of the MedDiet.
CONCLUSION
After 1 year of adherence to a Mediterranean-like dietary
pattern with vitamin D3 supplements the only significant
changes observed were in female participants with a BMI < 31.
However, it is important to stress there was a tendency
toward improvement of certain importance in some of the
inflammaging-related parameters measured, such as a greater T
cell response after TLRs stimulation. For the other parameters
studied, it is likely that in the absence of overt risk factors
or overly compromised immune function overt benefits cannot
be detected after a relatively short-term adoption of the
MedDiet.
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